Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 24.11.2025Adamed Pharma S.A. (AFD)2191BBISEPTOL 400 mg/80 mg (tbl 28x480 mg (blis.PVC/Al))24.11.2025O
 24.11.2025G.L. Pharma GmbH (GLH-2)9440BHedonin XR 300 mg tablety s predĺženým uvoľňovaním (tbl plg 60x300 mg (blis.PVC/PCTFE/Al))24.11.2025O
 24.11.2025G.L. Pharma GmbH (GLH-2)9553DSubmena 200 mikrogramov sublingválne tablety (tbl slg 30x1x200 µg (blis.PA/Al/PVC/Al/PET))24.11.2025O
 24.11.2025G.L. Pharma GmbH (GLH-2)9550DSubmena 100 mikrogramov sublingválne tablety (tbl slg 30x1x100 µg (blis.PA/Al/PVC/Al/PET))24.11.2025O
 24.11.2025G.L. Pharma GmbH (GLH-2)9462CEslibon 800 mg tablety (tbl 30x800 mg (blis.PVC/Al-transparent.))24.11.2025O
 21.11.2025Grifols Deutschland GmbH (GIO)4988CGamunex (sol inf 1x100 ml (liek.inj.skl.))21.11.2025R
 21.11.2025H. Lundbeck A/S (LUN-2)88480Cisordinol 10 mg (tbl flm 50x10 mg (obal HDPE))21.11.2025O
 21.11.2025MEDOCHEMIE Ltd. (MOE)7724CJIMANDIN 50 mg filmom obalené tablety (tbl flm 30x50 mg (blis.PA/Al/PVC/Al))21.11.2025R
 21.11.2025MEDOCHEMIE Ltd. (MOE)5883CKANILAD 50 mg filmom obalené tablety (tbl flm 14x50 mg (blis.PVC/PVDC/Al))21.11.2025R
 21.11.2025MEDOCHEMIE Ltd. (MOE)18668GYRABLOCK 400 mg (tbl flm 30x400 mg (fľ.PE))21.11.2025R
 21.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)8419AAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.))21.11.2025R
 21.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)4771BAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (plu igf 1x400 mg+1x1,6 ml (striek.inj.skl.napl.))21.11.2025R
 21.11.2025Teva B.V. (TEV-NL-4)0102FTeriflunomid Teva B.V. 14 mg (tbl flm 28 (1x28)x14 mg (blis.OPA/Al/PVC//Al))21.11.2025U
 21.11.2025EVER Valinject GmbH (EER)8416ETestosterón-undekanoát EVER Pharma 1000 mg/4 ml injekčný roztok (sol inj 1x4 ml/1000 mg (liek.inj.skl.jantár.))16.9.2025U
 21.11.2025ARDEZ Pharma, spol. s r.o. (ARZ)5050DTadard 5 mg (tbl flm 28x5 mg (blis.PVC/PVDC/Al))30.11.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)